Reslizumab Biosimilar - Research Grade

Human

IL5

5mg/ml

Human IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH2977

P05113

Blue ice

Interleukin-5 (IL5) is the principal cytokine governing eosinophil maturation and survival and a key target in asthma and eosinophilic disease research. Offered as an unconjugated, non-therapeutic analog of reslizumab, this research-grade anti-human IL5 recombinant monoclonal antibody is intended for research use only (RUO). It is manufactured to demanding in vivo standards, formulated for low endotoxin, and delivered in scalable milligram (mg) to gram (g) quantities for heavy-usage and high-throughput laboratories. It serves as a dependable neutralizing control and active reagent in cytokine assays, in vitro screening, and in vivo eosinophilic inflammation models.

Detects human IL5

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

4 weeks